- Home
- PHIO vs OP Comparison
PHIO vs OP Comparison
Compare PHIO & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- OP
- Stock Information
- Founded
- PHIO 2011
- OP 2021
- Country
- PHIO United States
- OP Greece
- Employees
- PHIO N/A
- OP N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- OP
- Sector
- PHIO Health Care
- OP
- Exchange
- PHIO Nasdaq
- OP Nasdaq
- Market Cap
- PHIO 12.1M
- OP 14.3M
- IPO Year
- PHIO N/A
- OP N/A
- Fundamental
- Price
- PHIO $2.04
- OP $1.13
- Analyst Decision
- PHIO Strong Buy
- OP
- Analyst Count
- PHIO 3
- OP 0
- Target Price
- PHIO $10.67
- OP N/A
- AVG Volume (30 Days)
- PHIO 139.7K
- OP 1.3M
- Earning Date
- PHIO 08-14-2025
- OP 12-02-2025
- Dividend Yield
- PHIO N/A
- OP N/A
- EPS Growth
- PHIO N/A
- OP N/A
- EPS
- PHIO N/A
- OP N/A
- Revenue
- PHIO N/A
- OP $19,435,000.00
- Revenue This Year
- PHIO N/A
- OP N/A
- Revenue Next Year
- PHIO N/A
- OP N/A
- P/E Ratio
- PHIO N/A
- OP N/A
- Revenue Growth
- PHIO N/A
- OP N/A
- 52 Week Low
- PHIO $0.97
- OP $1.07
- 52 Week High
- PHIO $9.79
- OP $79.25
- Technical
- Relative Strength Index (RSI)
- PHIO 42.33
- OP 31.39
- Support Level
- PHIO $1.96
- OP $1.07
- Resistance Level
- PHIO $2.13
- OP $1.68
- Average True Range (ATR)
- PHIO 0.10
- OP 0.19
- MACD
- PHIO 0.01
- OP 0.89
- Stochastic Oscillator
- PHIO 44.83
- OP 3.32
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.